Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Boston Scientific's book value per share for the quarter that ended in Mar. 2026 was CHF13.70.
During the past 12 months, Boston Scientific's average Book Value Per Share Growth Rate was 15.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 10.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 14.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Boston Scientific was 54.00% per year. The lowest was -14.70% per year. And the median was 12.30% per year.
Boston Scientific's current price is CHF35.59. Its book value per share for the quarter that ended in Mar. 2026 was CHF13.70. Hence, today's PB Ratio of Boston Scientific is 2.60.
During the past 13 years, the highest P/B Ratio of Boston Scientific was 7.19. The lowest was 2.53. And the median was 4.84.
Good Sign:
Boston Scientific Corp stock PB Ratio (=2.53) is close to 10-year low of 2.53.
Boston Scientific (XSWX:BSX) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Boston Scientific Book Value per Share Related Terms
Boston Scientific Book Value per Share Historical Data
* Premium members only.
The historical data trend for Boston Scientific's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:BSX vs EW, GEHC, MDT: Book Value per Share Comparison
For the Medical Devices subindustry, Boston Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's PB Ratio distribution charts can be found below:
* The bar in red indicates where Boston Scientific's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Book Value per Share of CHF13.70 mean?
Boston Scientific (XSWX:BSX) has a Book Value per Share of CHF13.70 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Book Value per Share too high?
Boston Scientific's current Book Value per Share is CHF13.70. Overall, Boston Scientific has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Book Value per Share compare to EW and GEHC?
Boston Scientific's Book Value per Share of CHF13.70 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Devices & Instruments company?
A good Book Value per Share depends on the Medical Devices & Instruments industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Boston Scientific and its competitors. Boston Scientific's current Book Value per Share is CHF13.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Boston Scientific (XSWX:BSX) has a current Book Value per Share of CHF13.70. The stock's GF Value™ is CHF85.51, compared to a current price of CHF35.59 — trading 58.4% below its estimated fair value. The current Book Value per Share is CHF13.70. Boston Scientific's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Boston Scientific (XSWX:BSX), the current Book Value per Share is CHF13.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (XSWX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of CHF35.59 is trading 58.4% below its estimated GF Value™ of CHF85.51.
Key valuation signals for XSWX:BSX:
Book Value per Share: CHF13.70
GF Value™: CHF85.51 vs. price of CHF35.59 (58.4% below fair value)
No single metric tells the full story. See the XSWX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
74GF Score
Get the complete analysis for XSWX:BSX
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BSX has been successfully added to your 
